- Home
- Software Solutions
- Resources
- Corporate
Phase I/II Trial of Radiation, Avastin and Tarceva for Pancreatic Adenocarcinoma
Sponsors:
| Phases:
| |
| Indications | Acronym: TART | |
| ||
Age Groups:
| Gender: Both | |
Names:
| Enrollment: 34 | |
Additional information about NCT00735306.